National Bank of Canada’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-10
Closed -$146 2885
2023
Q1
$146 Hold
10
﹤0.01% 2650
2022
Q4
$73 Hold
10
﹤0.01% 2722
2022
Q3
$0 Hold
10
﹤0.01% 2959
2022
Q2
$0 Hold
10
﹤0.01% 3064
2022
Q1
$0 Hold
10
﹤0.01% 3086
2021
Q4
$0 Buy
+10
New +$108 ﹤0.01% 2857

National Bank of Canada's AMYT Position: Q2 2023 in Review

National Bank of Canada sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 10 shares — an estimated $146 sold.

National Bank of Canada first reported a position in AMYT in Q4 2021 and held it in 6 quarters. The position peaked at $146 in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

  • National Bank of Canada reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • National Bank of Canada sold 10 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $146.
  • National Bank of Canada first reported a position in Amryt Pharma plc American Depositary Shares in Q4 2021 and held it in 6 quarters.
  • National Bank of Canada's Amryt Pharma plc American Depositary Shares position peaked at $146 in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on National Bank of Canada's 13F filing for Q2 2023, filed 26 Jul 2023.